DK0557876T3 - Anvendelse af xanthinderivater til behandling af muskelskader efter fuldstændig afbrydelse af blodcirkulationen - Google Patents

Anvendelse af xanthinderivater til behandling af muskelskader efter fuldstændig afbrydelse af blodcirkulationen

Info

Publication number
DK0557876T3
DK0557876T3 DK93102450.9T DK93102450T DK0557876T3 DK 0557876 T3 DK0557876 T3 DK 0557876T3 DK 93102450 T DK93102450 T DK 93102450T DK 0557876 T3 DK0557876 T3 DK 0557876T3
Authority
DK
Denmark
Prior art keywords
atoms
treatment
blood circulation
radical
muscle damage
Prior art date
Application number
DK93102450.9T
Other languages
English (en)
Inventor
Ismahan Dr Okyayuz-Baklouti
Maurice Dr Mars
Michael Alfred Gregory
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of DK0557876T3 publication Critical patent/DK0557876T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK93102450.9T 1992-02-22 1993-02-17 Anvendelse af xanthinderivater til behandling af muskelskader efter fuldstændig afbrydelse af blodcirkulationen DK0557876T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4205424 1992-02-22

Publications (1)

Publication Number Publication Date
DK0557876T3 true DK0557876T3 (da) 1997-05-26

Family

ID=6452327

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93102450.9T DK0557876T3 (da) 1992-02-22 1993-02-17 Anvendelse af xanthinderivater til behandling af muskelskader efter fuldstændig afbrydelse af blodcirkulationen

Country Status (13)

Country Link
EP (1) EP0557876B1 (da)
JP (1) JP3193800B2 (da)
KR (1) KR930017580A (da)
AT (1) ATE146078T1 (da)
AU (1) AU658979B2 (da)
CA (1) CA2089959A1 (da)
DE (1) DE59304710D1 (da)
DK (1) DK0557876T3 (da)
ES (1) ES2096115T3 (da)
GR (1) GR3022183T3 (da)
HU (1) HUT64472A (da)
TW (1) TW288977B (da)
ZA (1) ZA931184B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3792266B2 (ja) * 1994-06-16 2006-07-05 森精機興産株式会社 工作機械の熱変位補正方法及びその装置
DE19540798A1 (de) * 1995-11-02 1997-05-07 Hoechst Ag Alkylxanthinphosphonate und Alkylxanthinphosphinoxide und deren Verwendung als Arzneimittel
US5856330A (en) * 1996-07-31 1999-01-05 Hoechst Aktiengesellschaft Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin
US5981536A (en) * 1996-07-31 1999-11-09 Hoechst Aktiengesellschaft Use of xanthine derivatives for the modulation of apoptosis
US20070105878A1 (en) * 2005-10-03 2007-05-10 Andrew Reaume Purine formulations and methods for managing disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH608236A5 (da) * 1974-01-22 1978-12-29 Wuelfing J A Fa
DE3525801A1 (de) * 1985-07-19 1987-01-22 Hoechst Ag Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
GB8621870D0 (en) * 1986-09-11 1986-10-15 Beecham Group Plc Active compounds
ATE138266T1 (de) * 1990-11-07 1996-06-15 Hoechst Roussel Pharma Verwendung von xanthinen zur herstellung von arzneimitteln zur hemmung der vermehrung menschlicher retroviren

Also Published As

Publication number Publication date
GR3022183T3 (en) 1997-03-31
AU3376193A (en) 1993-08-26
ATE146078T1 (de) 1996-12-15
ZA931184B (en) 1993-09-16
CA2089959A1 (en) 1993-08-23
EP0557876A1 (de) 1993-09-01
KR930017580A (ko) 1993-09-20
JP3193800B2 (ja) 2001-07-30
HUT64472A (en) 1994-01-28
AU658979B2 (en) 1995-05-04
DE59304710D1 (de) 1997-01-23
JPH069634A (ja) 1994-01-18
EP0557876B1 (de) 1996-12-11
HU9300476D0 (en) 1993-05-28
TW288977B (da) 1996-10-21
ES2096115T3 (es) 1997-03-01

Similar Documents

Publication Publication Date Title
DK139287A (da) Tertiaere hydroxyalkylxanthiner, deres fremstilling og anvendelse som laegemidler
ES2150903T3 (es) Derivados de 2-aralcoxi y 2-alcoxi adenosina de utilidad como vasodilatadores coronarios y como agentes antihipertensivos.
SE9100342D0 (sv) Novel steroid esters
DK0557876T3 (da) Anvendelse af xanthinderivater til behandling af muskelskader efter fuldstændig afbrydelse af blodcirkulationen
ES2041246T3 (es) Procedimiento para la reticulacion de organopolisiloxanos.
ES2061959T3 (es) Derivados bencenicos sustituidos por fluor.
DE3855902D1 (de) Herstellungsverfahren für 2,5-Diamino-6-nitro-pyridinderivate sowie neue 2,5-Diamino-6-nitro-pyridinderivate
DE69119700D1 (de) Verwendung von Xanthinen zur Herstellung von Arzneimitteln zur Hemmung der Vermehrung menschlicher Retroviren
NZ216125A (en) Isoxazoles and pharmaceutical compositions
ES2096800T3 (es) Benzo(b)tiofen-3-il-piperazinas, un procedimiento para su preparacion y su uso como medicamentos.
ATE56944T1 (de) Substituierte 2-aminotetraline.
ATE18548T1 (de) Pyrrolidin-derivate, herstellung und verwendung als heilmittel.
DK0424248T3 (da) 20,21-dinoreburnamein med substitution i 15-stillingen, fremgangsmåde til deres fremstilling samt mellemprodukter til brug derved, deres anvendelse som lægemidler og præparater med indhold deraf
ES436233A2 (es) Procedimiento de preparacion de nuevos derivados de tetrahi-dro-m-oxazinas-sustituidas.
RU93004489A (ru) Лекарственное средство для профилактики и лечения повреждений мышц после прерывания кровообращения и способ лечения